Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treximet Long-Term Safety Study in Acute Migraine
NCT00442221Phase 3Completed
- Sponsor
- Pozen
- Start
- May 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of sumatriptan in migraine, sponsored by Pozen. Primary endpoints: Adverse Events at 12 months, Physical examination findings at 12 months and 2 more. Started May 2004; status: completed.
02
Drugs
sumatriptan
03
Conditions
migraine
Beyond the preview
Go deeper on NCT00442221.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00442221.